Sonnet BioTherapeutics CVR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SONN^ and buy or sell other stocks, ETFs, and their options commission-free!

About SONN^

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. It focuses on Fully Human Albumin Binding (FHAB) technology which utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. 

CEO
Raghu Rao, MBA
CEORaghu Rao, MBA
Employees
13
Employees13
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2011
Founded2011
Employees
13
Employees13

SONN^ Key Statistics

Market cap
8.92M
Market cap8.92M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
—
Dividend yield—
Average volume
1.71M
Average volume1.71M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$19.30
52 Week high$19.30
52 Week low
$1.08
52 Week low$1.08

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.